Bio-Rad Laboratories, Inc. v. Stilla Technologies, Inc. et al. (19-cv-11587).

Judge Young granted Stilla’s motion for a 90 day stay of this patent litigation related to droplet digital PCR technology. Bio-Rad accuses Stilla’s Naica™ System of infringement. Stilla sought to stay the case to allow its France-based staff, who are under severe travel and work restrictions, to focus on their development of a COVID-19 diagnostic test kit that uses the Naica™ System. Deciding to prolong a litigation is not the norm for Judge Young, who in December refused to accept a joint schedule that proposed trying the case in mid-February, 2021, stating that the case would go to trial no later than January 2021. The pandemic changes things, however, and the stay was granted just three days after it was sought, despite Stilla’s notice that Bio-Rad opposed the stay.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s